These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cytokines in systemic lupus erythematosus]. Robak E, Sysa-Jedrzejowska A, Robak T. Przegl Lek; 1996 Jul; 53(8):623-6. PubMed ID: 8999465 [Abstract] [Full Text] [Related]
5. Antioxidant and anti-inflammatory properties of a Cucumis melo LC. extract rich in superoxide dismutase activity. Vouldoukis I, Lacan D, Kamate C, Coste P, Calenda A, Mazier D, Conti M, Dugas B. J Ethnopharmacol; 2004 Sep; 94(1):67-75. PubMed ID: 15261965 [Abstract] [Full Text] [Related]
6. Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension. Kumar CA, Das UN. Med Sci Monit; 2000 Sep; 6(5):901-7. PubMed ID: 11208430 [Abstract] [Full Text] [Related]
11. Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression. Sthoeger ZM, Sharabi A, Molad Y, Asher I, Zinger H, Dayan M, Mozes E. J Autoimmun; 2009 Aug; 33(1):77-82. PubMed ID: 19346102 [Abstract] [Full Text] [Related]
12. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C, Li YF. Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258 [Abstract] [Full Text] [Related]
13. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus. Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F. Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908 [Abstract] [Full Text] [Related]
14. Cytokines expression in SLE nephritis. Gigante A, Gasperini ML, Afeltra A, Barbano B, Margiotta D, Cianci R, De Francesco I, Amoroso A. Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):15-24. PubMed ID: 21381496 [Abstract] [Full Text] [Related]
19. IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus. Baranda L, de la Fuente H, Layseca-Espinosa E, Portales-Pérez D, Niño-Moreno P, Valencia-Pacheco G, Abud-Mendoza C, Alcocer-Varela J, González-Amaro R. Rheumatology (Oxford); 2005 Dec; 44(12):1507-13. PubMed ID: 16251219 [Abstract] [Full Text] [Related]
20. The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis. Guo H, Leung JC, Chan LY, Chan TM, Lai KN. Rheumatology (Oxford); 2004 Mar; 43(3):286-93. PubMed ID: 14623950 [Abstract] [Full Text] [Related] Page: [Next] [New Search]